UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lifted by Heritage Family Offices LLP

Heritage Family Offices LLP lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,921 shares of the healthcare conglomerate’s stock after acquiring an additional 124 shares during the period. Heritage Family Offices LLP’s holdings in UnitedHealth Group were worth $1,530,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Capital & Planning LLC grew its position in UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock valued at $248,000 after purchasing an additional 79 shares in the last quarter. Brighton Jones LLC grew its holdings in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Union Bancaire Privee UBP SA bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $27,233,000. Revolve Wealth Partners LLC lifted its holdings in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Finally, McAdam LLC lifted its holdings in UnitedHealth Group by 29.1% during the 4th quarter. McAdam LLC now owns 980 shares of the healthcare conglomerate’s stock worth $496,000 after buying an additional 221 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. Oppenheimer reduced their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 14th. Mizuho dropped their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. Wall Street Zen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. TD Securities reiterated a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Finally, JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a research note on Thursday, May 15th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $439.17.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $304.27 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business’s 50 day simple moving average is $426.60 and its two-hundred day simple moving average is $490.74. The stock has a market capitalization of $276.01 billion, a P/E ratio of 19.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John H. Noseworthy bought 300 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the acquisition, the director now directly owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 over the last ninety days. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.